SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-041855
Filing Date
2024-10-21
Accepted
2024-10-21 21:13:40
Documents
1
Period of Report
2024-10-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4300
  Complete submission text file 0001493152-24-041855.txt   6049
Mailing Address 315 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94104
Business Address 315 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94104 (800) 304-9888
GT Biopharma, Inc. (Issuer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1524 CLOVERFIELD BOULEVARD SUITE E SANTA MONICA CA 90404
Business Address
URBAN ALAN LOUIS (Reporting) CIK: 0001534376 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40023 | Film No.: 241384484